SpyGlass Pharma, a private biotechnology company specializing in ophthalmology, has announced the co...

The California Institute for Regenerative Medicine (CIRM) has awarded a $6 million, two-year grant t...

Adverum Biotechnologies has released promising 52-week topline results from its Phase 2 LUNA trial a...

Emmecell has announced positive results from its U.S. multicenter Phase 1 trial evaluating EO2002, a...

A team of experts, convened by the National Institutes of Health (NIH), has defined five essential e...

Melt Pharmaceuticals has reported promising topline results from the pivotal Phase 3 trial of MELT-3...

Ocugen has released encouraging preliminary findings from the Phase 1 portion of its Phase 1/2 OCU41...

A study led by researchers at the University of California, San Diego, reveals that long-term variab...

Alkeus Pharmaceuticals has announced that the FDA has granted Rare Pediatric Disease and Fast Track ...

Samsung Bioepis and Biogen have announced that the European Commission (EC) has approved Opuviz 40 m...